Skip to main
OPCH

OPCH Stock Forecast & Price Target

OPCH Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

Option Care Health is experiencing a period of slower revenue growth, attributed to a slight decline in chronic therapies revenue and challenges related to patient census declines. Despite this, the company has potential growth levers identified for the second half of the year and expects a ramp in adjusted EBITDA to 55-57%. Additionally, the company has a comprehensive approach to data collection and analysis from over 200,000 sources in 38 languages, which could provide valuable insights and opportunities for growth.

Bears say

Option Care Health is facing headwinds in revenue and profit due to unexpected Stelara-related challenges and slower-than-expected growth in certain specialty therapies. The company's revised financial guidance for 2026 includes a reduced revenue forecast and lower-than-expected cash flow from operations, leading investors to doubt the achievability of the company's targets. Additionally, Option Care's exposure to Stelara is expected to significantly decrease after 2026, but the company is facing launch delays and slower-than-anticipated growth in certain therapies. These challenges could hinder the company's ability to meet its revenue and profit targets and may lead to downside risks for investors.

OPCH has been analyzed by 10 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Option Care Health (OPCH) Forecast

Analysts have given OPCH a Buy based on their latest research and market trends.

According to 10 analysts, OPCH has a Buy consensus rating as of Aug 24, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $75.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $75.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Option Care Health (OPCH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.